Advertisement
Research Article| Volume 13, ISSUE 1, P183-207, March 1993

Assessment of Hyperphosphatemia and Hypophosphatemia

  • Bourke Edmund
    Correspondence
    Address reprint requests to: Edmund Bourke, MD VAMC, Department of Medicine, 800 Poly Place, Room 970, Brooklyn, NY 11209.
    Affiliations
    Department of Medicine, Veterans Administration Medical Center, Brooklyn; and Department of Medicine, State University of New York, Health Science Center, Brooklyn, New York
    Search for articles by this author
  • Yanagawa Norimoto
    Affiliations
    UCLA/San Fernando Valley Program, San Fernando; and Department of Veteran’s Affairs, Olive View Medical Center, Sepulveda Veteran’s Administration Medical Center, Sepulveda, California
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30469-4
Assessment of Hyperphosphatemia and Hypophosphatemia
Previous ArticleAssessment of Hypocalcemia and Hypercalcemia
Next ArticleLaboratory Evaluation of Magnesium Status: Renal Function and Free Intracellular Magnesium Concentration
      This paper is only available as a PDF. To read, Please Download here.
      Methodologic aspects including causes of factitious hyperphosphatemia and hypophosphatemia are summarized. The differential diagnosis of hyperphosphatemia is reviewed under its three broad causes: decreased glomerular filtration rate, increased exogenous or endogenous phosphate load, and increased renal tubular phosphate reabsorption. The differential diagnosis of hypophosphatemia is reviewed under its three broad causes: inadequate gastrointestinal input, excess phosphate losses, and transcellular shifts. The consequences of hyperphosphatemia and hypophosphatemia are outlined with a focus on pathophysiologic and clinicochemical sequelae. A laboratory perspective is emphasized in outlining management strategies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Adler A.J.
        • Ferran N.
        • Berlyne G.M.
        Effect of inorganic phosphate on serum ionized calcium concentration in vitro: A reassessment of the “trade-off hypothesis.”.
        Kidney Int. 1985; 28: 932
        • Adler A.J.
        • Guidis S.
        • Berlyne G.M.
        Reduced renal phosphate threshold concentration in alcoholic cirrhosis.
        Miner Electrolye Metab. 1984; 10: 63
        • Ahmed K.Y.
        • Willis M.R.
        • Skinner R.K.
        • et al.
        Persistent hypophosphatemia and osteomalacia in dialysis patients not on oral phosphate binders: Response to DHT.
        Lancet. 1976; 2: 439
        • Annino J.S.
        • Pelman A.S.
        The effect of eating on some of the clinically important constituents of the blood.
        Am J Clin Pathol. 1954; 31: 155
        • Bergeron M.
        • Scriver C.R.
        Pathophysiology of renal hyperaminoacidurias and glucosuria.
        in: Seldin D.W. Giebisch G. The Kidney, Physiology and Pathophysiology. ed 2. Raven Press, New York1992: 2947
        • Betro M.G.
        • Pain R.W.
        Hypophosphatemia and hyperphosphatemia in a hospital population.
        Br Med J. 1972; 1: 273
        • Body J.J.
        • Cryer P.E.
        • Offord K.P.
        • et al.
        Epinephrine is a hypophosphatemic hormone in man.
        J Clin Invest. 1983; 71: 572
        • Bommer J.
        • Bonjour J.-P.
        • Ritz E.
        • et al.
        Parathyroid-independent changes in renal handling of phosphate in hyperthyroid rats.
        Kidney Int. 1979; 15: 325
        • Bowman T.E.
        • Whelan T.J.
        • Nelson T.G.
        Sudden death after phosphorus burns: Experimental observations of hypocalcemia, hyperphosphatemia and electrocardiographic abnormalities following production of a standard white phosphorus burn.
        Ann Surg. 1971; 174: 779
        • Brasier A.R.
        • Nussbaum S.R.
        Hungry bones syndrome.
        Am J Med. 1988; 84: 654
        • Bricker N.S.
        The biologic control system for phosphate in health and its modification in chronic renal failure.
        in: Berlyne G.M. Giovanetti S. Contributions to Nephrology. Basel Karger, New York1980: 46 (vol 20)
        • Bunker J.P.
        Metabolic effects of blood transfusion.
        Anesthesiology. 1966; 27: 446
        • Burch W.M.
        • Possillico J.T.
        Hypoparathyroidism after 131/therapy with subsequent return of parathyroid function.
        J Clin Endocrinol Metab. 1983; 57: 398
        • Card R.T.
        • Brain M.C.
        The “anemia” of childhood: Evidence for a physiologic response to hyperphosphatemia.
        N Engl J Med. 1973; 288: 388
        • Cardman E.C.
        • Lundberg W.B.
        • Bertino J.R.
        Hyperphosphatemia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt’s lymphoma and Burkitt cell leukemia.
        Am J Med. 1977; 62: 283
        • Caverzasso J.
        • Gloor H.J.
        • Fleisch H.
        • et al.
        Parathyroid hormone-independent adaptation of the renal handling of phosphate in response to renal mass reduction.
        Kidney Int. 1982; 21: 471
        • Clowes G.H.A.
        • Simeone F.A.
        Acute hypocalcemia in surgical patients.
        Ann Surg. 1957; 146: 530
        • Cole J.A.
        • Eber S.L.
        • Poelling R.E.
        • et al.
        A dual mechanism for regulation of kidney phosphate transport by parathyroid hormone.
        Am J Physiol. 1987; 253: E221
        • Contiguglia S.R.
        • Alfrey A.C.
        • Miller N.L.
        • et al.
        Nature of soft tissue calcification in uremia.
        Kidney Int. 1973; 4: 229
        • Corredor D.G.
        • Sabeh G.
        • Mendelsohn L.D.
        • et al.
        Enhanced post glucose hypophosphatemia during starvation therapy of obesity.
        Metabolism. 1969; 18: 754
        • Craddock P.R.
        • Yawata Y.
        • Van Santen L.
        • et al.
        Acquired phagocyte dysfunction: A complication of the hypophosphatemia of parenteral hyperalimentation.
        N Engl J Med. 1974; 290: 1403
        • Danowski T.S.
        • Gillespie H.K.
        • Fergus E.B.
        • et al.
        Significance of blood sugar and serum electrolyte changes in cirrhosis following glucose, insulin, glucagon, or epinephrine.
        Yale J Biol Med. 1956-57; 29: 361
        • Denborough M.A.
        • Forster J.F.A.
        • Hudson M.C.
        • et al.
        Biochemical changes in malignant hyperpyrexia.
        Lancet. 1970; 2: 1137
        • Donhowe J.M.
        • Freier E.F.
        • Wong E.T.
        • et al.
        Factitious hypophosphatemia related to mannitol therapy.
        Clin Chem. 1981; 27: 1765
        • Ettinger D.S.
        • Harker W.G.
        • Gerry H.W.
        • et al.
        Hyperphosphatemia, hypocalcemia and transient renal failure. Results of cytoxic treatment of acute lymphoblastic leukemia.
        JAMA. 1978; 239: 2472
        • Färber E.
        ATP and cell integrity.
        Fed Proc. 1973; 32: 1534
        • Feinfeld D.A.
        • Sherwood L.M.
        Parathyroid hormone and 1,25 (OH)2D3 in chronic renal failure.
        Kidney Int. 1988; 33: 1049
        • Fiske C.H.
        • Subbarow Y.
        The colorimetric determination of phosphorus.
        J Biol Chem. 1925; 66: 375
        • Gipstein R.M.
        • Coburn J.W.
        • Adams D.A.
        • et al.
        Calciphylaxis in man: a syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal disease.
        Arch Intern Med. 1976; 136: 1273
        • Gitelis S.
        • Ryan W.G.
        • Rosenberg G.
        • et al.
        Adult-onset hypophosphatemic osteomalacia secondary to neoplasm. A case report and review of pathophysiology.
        J Bone Joint Surg. 1986; 68: 134
        • Glorieux F.H.
        Rickets, the continuing challenge.
        N Engl J Med. 1992; 325: 1875
        • Gorman J.M.
        • Cohen B.S.
        • Liebowicz M.R.
        • et al.
        Blood gas changes and hypophosphatemia in lactate-induced panic.
        Arch Gen Psychiatry. 1986; 43: 1067
        • Gray R.W.
        • Haasch M.L.
        • Brown C.E.
        Regulation of plasma 1,25-(OH)2D by phosphate: Evidence against a role for total or acid-soluble renal phosphate content.
        Calcif Tissue Int. 1983; 35: 773
        • Guntupalli J.
        • Rogers A.
        • Bourke E.
        Effect of insulin on renal phosphorus handling in the rat: Interaction with PTH and nicotinamide.
        Am J Physiol. 1985; 249: F610
        • Guntupalli J.
        • Matthews B.
        • Carlin B.
        • et al.
        Effect of acute hypercapnia on PTH-stimulated phosphaturia in dietary Prdeprived rat.
        Am J Physiol. 1987; 253: F34
        • Guntupalli K.K.
        • Sladen A.
        • Selker R.G.
        • et al.
        Effects of induced total-body hyperthermia on phosphorus metabolism in humans.
        Am J Med. 1984; 77: 250
        • Hall K.W.
        • Dobson K.E.
        • Dalton J.G.
        • et al.
        Metabolic abnormalities associated with intentional theophylline overdose.
        Ann Intern Med. 1954; 101: 457
        • Harsh H.
        Neuroleptic malignant syndrome: Physiological and laboratory findings in a series of nine cases.
        J Clin Psychiatry. 1987; 48: 328
        • Hart G.R.
        • Anderson R.J.
        • Crumpler C.P.
        • et al.
        Epidemic classical heat stroke: Clinical characteristics and course of 28 patients.
        Medicine [Baltimore]. 1982; 61: 189
        • Hill G.L.
        • Guinn E.J.
        • Dudrick S.J.
        Phosphorus distribution in hyperalimentation induced hypophosphatemia.
        J Surg Res. 1976; 20: 527
        • Huag T.O.
        Time course of changes in concentration of some plasma components after furosemide.
        Br Med J. 1976; 3: 622
        • Jones J.E.
        • Shane S.R.
        • Jacobs W.H.
        Magnesium balance studies in chronic alcoholism.
        Ann NY Acad Sei. 1975; 252: 274
        • Karlinsky M.L.
        • Haut L.
        • Buddington B.
        • et al.
        Preservation of renal function in experimental glomerulonephritis.
        Kidney Int. 1982; 17: 293
        • Knöchel J.P.
        The pathophysiology and clinical characteristics of severe hypophosphatemia.
        Arch Intern Med. 1977; 137: 203
        • Knöchel J.P.
        • Caskey J.H.
        On the mechanism of hypophosphatemia in acute heat stroke.
        JAMA. 1977; 238: 425
        • Knöchel J.P.
        Hypophosphatemia in the alcoholic.
        Arch Intern Med. 1980; 140: 613
        • Knöchel J.P.
        Rhabdomyolysis and myoglobinuria.
        Ann Rev Med. 1982; 33: 435
        • Knöchel J.P.
        Hypophosphatemia and phosphorus deficiency.
        in: Brenner B.M. Rector Jr, F.C. The Fddney. ed 4. WB Saunders, Philadelphia1991: 888
        • Knöchel J.P.
        The clinical and physiological implications of phosphorus deficiency.
        in: Seldin D.W. Giebisch G. The Kidney, Physiology and Pathophysiology. ed 2. Raven Press, New York1992: 2533
        • Knox F.
        • Haramati A.
        Renal regulation of phosphate excretion.
        in: Seldin D.W. Giebisch G. The Kidney, Physiology and Pathophysiology. Raven Press, New York1985: 1390
        • Kuzela D.C.
        • Huffer W.E.
        • Conger J.D.
        • et al.
        Soft tissue calcification in chronic dialysis patients.
        Am J Pathol. 1977; 86: 403
        • LaFlamme G.H.
        • Jowsey J.
        Bone and soft tissue changes with oral phosphate supplements.
        J Clin Invest. 1972; 51: 2834
        • Leehey D.J.
        • Daugirdas J.T.
        • Ing T.
        • et al.
        Spurious hyperphosphatemia due to hyperlipidemia.
        Arch Intern Med. 1985; 145: 743
        • Lemann Jr, I.
        • Gray R.W.
        • Adams N.D.
        Is there a disorder of phosphate metabolism in idiopathic hypercalciuria.
        Miner Electrolyte Metab. 1979; 2: 245
        • Levine B.S.
        • Kraut J.A.
        • Mishler D.R.
        • et al.
        Effect of acute acidemia on phosphate uptake by renal proximal tubular brush-border membranes.
        Am J Physiol. 1986; 251: F889
        • Levy L.A.
        Severe hypophosphatemia as a complication of the treatment of hypothermia.
        Arch Intern Med. 1980; 140: 128
        • Lindsay R.
        • Coutts J.R.T.
        • Hart D.M.
        The effect of endogenous oestrogen on plasma and urinary calcium and phosphate in oophorectomized women.
        Clin Endocrinol [Oxford]. 1977; 6: 87
        • Malluche H.H.
        • Werner E.
        • Ritz E.
        Intestinal absorption of calcium in incipient advanced renal failure.
        Miner Electrolyte Metab. 1978; 1: 263
        • Malluche H.H.
        • Fauger M.C.
        • Fliedler R.M.
        • et al.
        Calcitriol, parathyroid hormone, and accumulation of aluminum in bone of dogs with renal failure.
        J Clin Invest. 1987; 79: 754
        • Massry S.G.
        • Coburn J.W.
        Divalent ion metabolism and renal osteodystrophy.
        in: Massry S.G. Sellers A.L. Clinical Aspects of Uremia and Dialysis. Charles C Thomas, Springfield, IL1976: 304
        • Massry S.G.
        • Ritz E.
        The pathogenesis of secondary hyperparathyroidism. Is there a controversy?.
        Arch Intern Med. 1978; 138: 853
        • Miller W.L.
        • Meyer W.J.
        • Bartter F.C.
        Intermittent hyperphosphatemia, polyuria, and seizures—a new familial disorder.
        J Pediatr. 1975; 86: 233
        • Montanari A.
        • Borghi L.
        • Curti A.
        • et al.
        Acute hypophosphatemia during total parenteral nutrition in man: Its effect on muscle cell composition.
        Adv Exp Med Biol. 1982; 151: 229
        • Mostellar M.E.
        • Tuttle Jr, E.P.
        Effects of alkalosis on plasma concentration and urinary excretion of inorganic phosphate in man.
        J Clin Invest. 1964; 43: 138
        • Munk P.
        • Freedman M.H.
        • Greenberg M.L.
        • et al.
        Hemoglobin-oxygen affinity in hypophosphatemic rickets.
        Acta Paediatr Scand. 1976; 65: 97
        • Murer H.
        • Biber J.
        Renal tubular phosphate transport: Cellular mechanisms.
        in: Seldin D.W. Giebisch G. The Kidney: Physiology and Pathophysiology. ed 2. Raven Press, New York1992: 2481
        • O’Connor L.R.
        • Klein K.L.
        • Bethune J.E.
        Hyperphosphatemia in lactic acidosis.
        N Engl J Med. 1977; 297: 707
        • Pak C.Y.C.
        • Nicar M.J.
        • Krejs G.J.
        Intestinal absorption of calcium, magnesium, phosphate and oxalate: Deviation from normal in idiopathic urolithiasis.
        in: Schwüle P.O. Smith L.H. Robertson W.G. Urolithiasis and Related Clinical Research. Plenum Press, New York1985: 127
        • Portale A.A.
        • Booth B.E.
        • Halloran B.P.
        • et al.
        Effect of dietary phosphate on circulating concentration of 1,25-dihydroxy vitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
        J Clin Invest. 1984; 73: 1580
        • Portale A.A.
        • Halloran B.P.
        • Murphy M.M.
        • et al.
        Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans.
        J Clin Invest. 1986; 77: 7
        • Poujeol P.
        • Vandewalle A.
        Phosphate uptake by proximal cells isolated from rabbit kidney: Role of dexamethasone.
        Am J Physiol. 1985; 249: F74
        • Prince M.J.
        • Schaeffer P.C.
        • Goldsmith R.S.
        • et al.
        Hyperphosphatemic tumoral calcinosis. Association with elevation of serum 1,25 dihydroxycholecalciferol concentrations.
        Ann Intern Med. 1982; 96: 586
        • Puschett J.B.
        • Winaver J.
        • Chen T.C.
        Study of the renal tubular sites and mechanisms of action of parathyroid hormone.
        Miner Electrolyte Metab. 1981; 6: 190

      74. Rasmussen H, Reifenstein EC Jr: In Williams RH (ed): Textbook of Endocrinology, ed 3. Phüadelphia, WB Saunders, 1962, p 798

        • Ritz E.
        • Malluche H.H.
        • Krempien B.
        • et al.
        Pathogenesis of renal osteodystrophy: Role of phosphate and skeletal resistance to PTH.
        in: Massry S.G. Rapadi A. Ritz E. Phosphate and Other Minerals. Plenum Press, New York1978: 423
        • Ritz E.
        • Kreusser W.
        • Bommer J.
        Effects of hormones other than parathyroid hormone on renal handling of phosphate.
        in: Massry S.G. Fleisch H. Renal Handling of Phosphate. Plenum Press, New York1980: 137
        • Roenbaum R.W.
        • Hruska K.A.
        • Korkor A.
        • et al.
        Decreased phosphate reabsorption after transplantation evidence for a mechanism independent of calcium and parathyroid hormone.
        Kidney Int. 1981; 19: 568
        • Rost C.R.
        • Bikle D.D.
        • Kaplan R.A.
        In vitro stimulation of 25-hydroxycholecalciferol 1-hydroxylase by parathyroid hormone in chick kidney slices: Evidence for a role for adenosine 3′,5′-monophosphate.
        Endocrinology. 1981; 108: 1002
        • Sherrard D.J.
        Aluminum and renal osteodystrophy.
        Semin Nephrol. 1986; 6: 5
        • Slatopolsky E.
        The interaction of parathyroid hormone and aluminum in renal osteodystrophy.
        Kidney Int. 1987; 31: 842
        • Smith E.C.
        • Valika K.S.
        • Woo J.E.
        • et al.
        Serum phosphate abnormalities in sickle cell anemia.
        Proc Soc Exp Biol Med. 1981; 168: 254
        • Sotos J.F.
        • Cutler E.A.
        • Finkei M.A.
        • et al.
        Hypocalcemic coma following two pediatric phosphate enemas.
        Pediatrics. 1977; 60: 305
        • Suki W.
        • Martinez-Maldonado M.
        • Rouse D.
        • et al.
        Effect of expansion of the extracellular fluid volume on renal phosphate handling.
        J Clin Invest. 1969; 48: 1888
        • Trivedi B.
        • Danforth W.H.
        Effects of pH on the kinetics of frog muscle phosphofructoki-nase.
        J Biol Chem. 1966; 241: 4110
        • Vianna M.J.
        Severe hypophosphatemia due to hypokalemia.
        JAMA. 1971; 215: 1497
        • Walton R.J.
        • Russell R.G.G.
        • Smith R.
        Changes in renal and extrarenal handling of phosphate induced by sodium editronate (EHDP) in man.
        Clin Sei. 1975; 49: 45
        • Weinberg J.
        • Adler A.J.
        Spurious hyperphosphatemia in patients with dysglobulinemia.
        Miner Electrolyte Metab. 1989; 15: 185
        • Wilkie D.
        Profound hypophosphatemia in patients collapsing after a “fun run” [letter].
        Br Med J. 1986; 292: 692
        • Windus D.W.
        • Stokes T.J.
        • Julian B.A.
        • et al.
        Fatal rhizopus infections in hemodialysis patients receiving deferoxamine.
        Ann Intern Med. 1987; 107: 678
        • Woods H.F.
        • Eggleston L.V.
        • Krebs H.A.
        The cause of hepatic accumulation of fructose-1-phosphate on fructose loading.
        Biochem J. 1970; 119: 501
        • Wortsman J.
        • Pak C.Y.C.
        • Bartter F.C.
        • et al.
        Pathogenesis of osteomalacia and secondary hyperparathyroidism after gastrectomy.
        Am J Med. 1972; 52: 556

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30469-4

      Copyright

      © 1993 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX